KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Acquisitions (2016 - 2024)

Globus Medical (GMED) has disclosed Acquisitions for 12 consecutive years, with $100000.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Acquisitions fell 99.97% year-over-year to $100000.0, compared with a TTM value of $100000.0 through Dec 2025, down 99.43%, and an annual FY2025 reading of $252.5 million, up 1332.07% over the prior year.
  • Acquisitions was $100000.0 for Q3 2024 at Globus Medical, down from $4.9 million in the prior quarter.
  • Across five years, Acquisitions topped out at $293.4 million in Q3 2023 and bottomed at $100000.0 in Q3 2024.
  • Average Acquisitions over 4 years is $35.7 million, with a median of $3.8 million recorded in 2023.
  • The sharpest move saw Acquisitions soared 544.05% in 2020, then plummeted 99.97% in 2024.
  • Year by year, Acquisitions stood at $1.5 million in 2020, then soared by 1928.15% to $30.3 million in 2022, then soared by 869.48% to $293.4 million in 2023, then tumbled by 99.97% to $100000.0 in 2024.
  • Business Quant data shows Acquisitions for GMED at $100000.0 in Q3 2024, $4.9 million in Q2 2024, and $12.6 million in Q1 2024.